Vanguard Group Inc Cardiff Oncology, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,115,369 shares of CRDF stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,115,369

Previous 2,284,917 36.34%

Holding current value

$10.6 Million

Previous $9.92 Million 1.35%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$3.14 - $4.75 $2.61 Million - $3.94 Million	830,452 Added 36.34%	3,115,369 $9.78 Million
Q4 2024 Feb 11, 2025	BUY	$2.31 - $5.35 $262,122 - $607,080	113,473 Added 5.23%	2,284,917 $9.92 Million
Q3 2024 Nov 13, 2024	BUY	$2.05 - $2.77 $71,967 - $97,243	35,106 Added 1.64%	2,171,444 $5.8 Million
Q2 2024 Aug 13, 2024	BUY	$2.22 - $5.89 $477,479 - $1.27 Million	215,081 Added 11.19%	2,136,338 $4.74 Million
Q1 2024 May 10, 2024	BUY	$1.46 - $5.91 $13,823 - $55,955	9,468 Added 0.5%	1,921,257 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.55 $29,883 - $48,249	-31,129 Reduced 1.6%	1,911,789 $2.83 Million
Q4 2022 Feb 10, 2023	BUY	$1.22 - $1.66 $1,061 - $1,444	870 Added 0.04%	1,942,918 $2.72 Million
Q3 2022 Nov 14, 2022	BUY	$1.54 - $3.21 $287,043 - $598,318	186,392 Added 10.62%	1,942,048 $2.99 Million
Q2 2022 Aug 12, 2022	SELL	$1.17 - $2.61 $184,575 - $411,745	-157,757 Reduced 8.24%	1,755,656 $3.86 Million
Q1 2022 May 13, 2022	SELL	$2.11 - $7.25 $96,051 - $330,034	-45,522 Reduced 2.32%	1,913,413 $4.75 Million
Q4 2021 Feb 14, 2022	BUY	$5.18 - $7.24 $756,212 - $1.06 Million	145,987 Added 8.05%	1,958,935 $11.8 Million
Q3 2021 Nov 12, 2021	BUY	$5.01 - $7.58 $836,189 - $1.27 Million	166,904 Added 10.14%	1,812,948 $12.1 Million
Q2 2021 Aug 13, 2021	BUY	$6.65 - $10.04 $10.9 Million - $16.5 Million	1,646,044 New	1,646,044 $10.9 Million

Others Institutions Holding CRDF

# of Institutions

124

Shares Held

29M

Call Options Held

900K

Put Options Held

234K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $148M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cardiff Oncology, Inc. Transaction History